Skechers U S A, Inc (SKX) concluded trading on Thursday at a closing price of $49.35, with 5.72 million shares of worth about $282.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -25.23% during that period and on April 10, 2025 the price saw a loss of about -2.43%. Currently the company’s common shares owned by public are about 129.85M shares, out of which, 129.26M shares are available for trading.
Stock saw a price change of 0.80% in past 5 days and over the past one month there was a price change of -12.50%. Year-to-date (YTD), SKX shares are showing a performance of -26.61% which decreased to -15.13% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $44.50 but also hit the highest price of $78.85 during that period. The average intraday trading volume for Skechers U S A, Inc shares is 2.90 million. The stock is currently trading -9.85% below its 20-day simple moving average (SMA20), while that difference is down -18.24% for SMA50 and it goes to -23.77% lower than SMA200.
Skechers U S A, Inc (NYSE: SKX) currently have 129.85M outstanding shares and institutions hold larger chunk of about 83.48% of that.
The stock has a current market capitalization of $7.37B and its 3Y-monthly beta is at 1.07. PE ratio of stock for trailing 12 months is 11.89, while it has posted earnings per share of $4.15 in the same period. Its PEG reads 1.21 and has Quick Ratio of 1.12 while making debt-to-equity ratio of 0.51. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SKX, volatility over the week remained 12.64% while standing at 5.97% over the month.
Stock’s fiscal year EPS is expected to rise by 0.35% while it is estimated to increase by 16.12% in next year. EPS is likely to shrink at an annualized rate of 9.82% for next 5-years, compared to annual growth of 13.08% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on December 10, 2024 offering a Neutral rating for the stock and assigned a target price of $65 to it. On July 23, 2024, Morgan Stanley Upgrade their recommendations, while on June 07, 2024, BofA Securities Upgrade their ratings for the stock with a price target of $87. Stock get an Overweight rating from Barclays on April 01, 2024.
